Literature DB >> 15585928

Regulatory T-cells in antitumor therapy: isolation and functional testing of CD4+CD25+ regulatory T-cells.

Helmut Jonuleit1, Edgar Schmitt.   

Abstract

Naturally occurring CD4+CD25+ T regulatory cells originate from the thymus and play a central role regarding the maintenance of peripheral tolerance by suppression of autoreactive T-cell populations. However, T regulatory cells can have beneficial as well as harmful effects. On the one hand, they prevent a variety of autoimmune and inflammatory diseases; but on the other hand, they concomitantly inhibit antitumor immune reactions by suppressing tumor-specific T-cell responses. Therefore, these ambivalent properties of T regulatory cells require detailed investigation especially with respect to a potential therapeutic exploitation of these cells. A prerequisite for such analyses is the isolation of pure T regulatory cells and the establishment of functional tests for the analysis of their suppressive properties, since no specific markers for CD4+CD25+ T regulatory cells are known so far. In this chapter, techniques applying immunomagnetic beads have been used to establish an efficient method for isolation of human as well as murine regulatory T-cells. A combination of positive and negative selection steps using immunomagnetic beads of different sizes yields preparations of functional, active CD4+CD25+ regulatory T-cells with high purity. Additionally, co-culture assays for functional characterization of isolated CD4+CD25+ regulatory T-cells are described that are able to detect their suppressive properties for conventional CD4+ T-cells with high sensitivity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15585928     DOI: 10.1385/1-59259-862-5:285

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  4 in total

1.  Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma.

Authors:  Peter Attia; Ajay V Maker; Leah R Haworth; Linda Rogers-Freezer; Steven A Rosenberg
Journal:  J Immunother       Date:  2005 Nov-Dec       Impact factor: 4.456

2.  A key role of GARP in the immune suppressive tumor microenvironment.

Authors:  Susanne A Hahn; Annemarie Neuhoff; Jenny Landsberg; Jonathan Schupp; Daniela Eberts; Petra Leukel; Matthias Bros; Martin Weilbaecher; Detlef Schuppan; Stephan Grabbe; Thomas Tueting; Volker Lennerz; Clemens Sommer; Helmut Jonuleit; Andrea Tuettenberg
Journal:  Oncotarget       Date:  2016-07-12

3.  Rational Combination of Parvovirus H1 With CTLA-4 and PD-1 Checkpoint Inhibitors Dampens the Tumor Induced Immune Silencing.

Authors:  Katrin Goepfert; Christiane Dinsart; Jean Rommelaere; Friedrich Foerster; Markus Moehler
Journal:  Front Oncol       Date:  2019-05-28       Impact factor: 6.244

4.  Kinome Profiling of Regulatory T Cells: A Closer Look into a Complex Intracellular Network.

Authors:  Andrea Tuettenberg; Susanne A Hahn; Johanna Mazur; Aslihan Gerhold-Ay; Jetse Scholma; Iris Marg; Alexander Ulges; Kazuki Satoh; Tobias Bopp; Jos Joore; Helmut Jonuleit
Journal:  PLoS One       Date:  2016-02-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.